Mostafa Ghanei Selected Research

Bronchiolitis Obliterans

8/2014	The role of N-acetylcysteine in the management of acute and chronic pulmonary complications of sulfur mustard: a literature review.
11/2012	Clinical and paraclinical guidelines for management of sulfur mustard induced bronchiolitis obliterans; from bench to bedside.
8/2012	GERD related micro-aspiration in chronic mustard-induced pulmonary disorder.
5/2011	Helium:oxygen versus air:oxygen noninvasive positive-pressure ventilation in patients exposed to sulfur mustard.
6/2010	Overexpression of transforming growth factor (TGF)-beta1 and TGF-beta3 genes in lung of toxic-inhaled patients.
1/2010	Discrepancy between mRNA and Protein Expression of Neutrophil Gelatinase-Associated Lipocalin in Bronchial Epithelium Induced by Sulfur Mustard.
11/2008	N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test.
6/2008	An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients.
3/2008	Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test.
11/2004	Efficacy of concomitant administration of clarithromycin and acetylcysteine in bronchiolitis obliterans in seventeen sulfur mustard-exposed patients: An open-label study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mostafa Ghanei Research Topics

Disease

34	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2007
18	Lung Injury 12/2020 - 06/2005
18	Lung Diseases (Lung Disease) 02/2019 - 11/2004
15	Inflammation (Inflammations) 01/2021 - 12/2004
14	Dyspnea (Shortness of Breath) 09/2021 - 11/2004
12	Neoplasms (Cancer) 01/2022 - 08/2009
11	Bronchiolitis Obliterans 08/2014 - 11/2004
8	Lung Neoplasms (Lung Cancer) 03/2022 - 09/2006
8	Wounds and Injuries (Trauma) 11/2021 - 10/2010
8	Bronchiolitis 01/2014 - 06/2005
7	COVID-19 08/2022 - 12/2020
7	Cough 11/2014 - 11/2004
6	Asthma (Bronchial Asthma) 01/2018 - 12/2007
5	Infections 01/2021 - 02/2011
5	Chronic Bronchitis 10/2018 - 11/2004
4	Hypoxia (Hypoxemia) 01/2018 - 12/2014
4	Chronic Cough 07/2015 - 12/2006
4	Airway Remodeling 01/2014 - 06/2010
4	Hemoptysis 01/2014 - 09/2006
3	Pneumonia (Pneumonitis) 06/2021 - 01/2014
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 08/2008
3	Necrosis 10/2018 - 01/2010
3	Respiratory Insufficiency (Respiratory Failure) 10/2018 - 05/2011
3	Blister (Bulla) 11/2017 - 05/2002
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2017 - 12/2016
3	Carcinogenesis 01/2017 - 08/2009
3	Tuberculosis (Tuberculoses) 01/2017 - 01/2014
3	Gastroesophageal Reflux (GERD) 07/2015 - 01/2012
3	Poisoning 10/2010 - 11/2008
2	Pleural Tuberculosis 03/2016 - 03/2004
2	Obstructive Lung Diseases (Obstructive Lung Disease) 03/2016 - 01/2014
2	Sleep Wake Disorders 12/2014 - 06/2012
2	Laryngismus (Laryngospasm) 04/2013 - 01/2013
2	Pathologic Constriction (Stenosis) 12/2011 - 12/2004
2	Fibrosis (Cirrhosis) 09/2011 - 12/2004
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2011 - 06/2005
2	Bronchiolitis Obliterans Syndrome 11/2008 - 03/2008

Drug/Important Bio-Agent (IBA)

76	Mustard Gas (Sulfur Mustard)IBA 11/2021 - 05/2002
17	Proteins (Proteins, Gene)FDA Link 04/2021 - 03/2004
10	CytokinesIBA 01/2021 - 06/2010
8	Prednisolone (Predate)FDA LinkGeneric 09/2021 - 06/2005
8	AntioxidantsIBA 01/2018 - 11/2008
7	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2021 - 11/2005
7	Bronchodilator Agents (Bronchodilators)IBA 01/2021 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 03/2022 - 06/2010
5	Interleukin-6 (Interleukin 6)IBA 10/2017 - 12/2009
5	Pharmaceutical PreparationsIBA 04/2017 - 12/2004
5	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2016 - 12/2004
4	Therapeutic UsesIBA 10/2018 - 11/2004
4	Salmeterol Xinafoate (Serevent)FDA Link 01/2018 - 01/2012
4	GoldIBA 08/2016 - 12/2009
3	Endoplasmic Reticulum Chaperone BiPIBA 04/2021 - 01/2017
3	AntibodiesIBA 04/2021 - 09/2012
3	SteroidsIBA 01/2021 - 11/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2011
3	InterleukinsIBA 01/2019 - 10/2010
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2018 - 08/2007
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 11/2004
3	VaccinesIBA 01/2017 - 12/2016
3	Oxidants (Oxidizing Agents)IBA 01/2016 - 11/2008
3	Protein Isoforms (Isoforms)IBA 04/2015 - 10/2009
3	Oxygen (Dioxygen)IBA 04/2013 - 05/2011
3	Expectorants (Mucolytics)IBA 04/2013 - 11/2004
3	Beclomethasone (Beclometasone)FDA Link 01/2012 - 08/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2004
2	Immunoglobulin E (IgE)IBA 01/2021 - 01/2019
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2020 - 08/2008
2	Messenger RNA (mRNA)IBA 08/2018 - 08/2016
2	Glutathione (Reduced Glutathione)IBA 01/2018 - 01/2014
2	AutoantibodiesIBA 10/2017 - 01/2017
2	Interleukin-4 (Interleukin 4)IBA 10/2017 - 01/2014
2	Formaldehyde (Formol)FDA Link 07/2017 - 08/2009
2	ParaffinIBA 07/2017 - 08/2009
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2017 - 12/2016
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017 - 12/2016
2	C-Reactive ProteinIBA 01/2017 - 02/2014
2	AntigensIBA 12/2016 - 01/2014
2	Metalloproteases (Metalloproteinases)IBA 12/2016 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 08/2016 - 01/2014
2	Interleukin-17 (Interleukin 17)IBA 08/2016 - 02/2015
2	Long Noncoding RNAIBA 08/2016 - 02/2016
2	Tiotropium Bromide (Spiriva)FDA Link 03/2016 - 12/2015
2	Clostridium perfringens epsilon-toxinIBA 10/2015 - 04/2013
2	AcidsIBA 07/2015 - 01/2012
2	Peptide Hydrolases (Proteases)FDA Link 04/2015 - 06/2011
2	Pancreatic Elastase (Elastase)IBA 04/2015 - 05/2013
2	Clarithromycin (Biaxin)FDA LinkGeneric 08/2014 - 11/2004
2	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 01/2012 - 12/2007
2	HaptoglobinsIBA 01/2011 - 10/2009
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2010 - 06/2010
2	MacrolidesIBA 12/2007 - 11/2004
2	Albuterol (Salbutamol)FDA LinkGeneric 12/2007 - 08/2007

Therapy/Procedure

28	Therapeutics 09/2021 - 11/2005
3	Aftercare (After-Treatment) 01/2019 - 07/2008
3	Immunotherapy 08/2017 - 12/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2018 - 04/2017
2	Lasers (Laser) 01/2017 - 04/2015
2	Nebulizers and Vaporizers (Inhaler) 01/2014 - 08/2007
2	Tracheostomy 04/2013 - 01/2013